Back to Journals » OncoTargets and Therapy » Volume 1 » default

OncoTargets and Therapy

ISSN: 1178-6930

Archive: Volume 1, 2008

Recombinant human thyroid stimulating hormone in 2008: focus on thyroid cancer management

Ann Gramza, Kathryn G Schuff

OncoTargets and Therapy 2008, 1:87-101

Published Date: 11 January 2009

Topotecan in the treatment of relapsed small cell lung cancer

Elisabeth Quoix

OncoTargets and Therapy 2008, 1:79-86

Published Date: 1 December 2008

Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling

Wessen Maruwge, Pádraig D’Arcy, Annika Folin, Slavica Brnjic, Johan Wejde, et al

OncoTargets and Therapy 2008, 1:67-78

Published Date: 27 November 2008

Polyclonal B-cell lymphocytosis with binucleated lymphocytes (PPBL)

Xavier Troussard, Edouard Cornet, Jean-François Lesesve, Carine Kourel, Hossein Mossafa

OncoTargets and Therapy 2008, 1:59-66

Published Date: 15 October 2008

Relationship between arachidonic acid pathway and human renal cell carcinoma

Masahide Matsuyama, Rikio Yoshimura

OncoTargets and Therapy 2008, 1:41-48

Published Date: 13 October 2008

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer

Thomas Powles, Siobhan McFaul, Justin Stebbing, Peter Wilson, Tim Oliver et al

OncoTargets and Therapy 2008, 1:35-39

Published Date: 30 September 2008

Targeted treatment of advanced and metastatic breast cancer with lapatinib

Brendan Corkery, Norma O’Donovan, John Crown

OncoTargets and Therapy 2008, 1:21-34

Published Date: 16 September 2008

The epidermal growth factor receptor family in breast cancer

Angelos K Koutras, T R Jeffry Evans

OncoTargets and Therapy 2008, 1:5-19

Published Date: 14 September 2008

Incompletely excised basal cell carcinomas: Our guidelines

P Longhi, M Paola Serra, E Robotti

OncoTargets and Therapy 2008, 1:1-4

Published Date: 2 July 2008